Literature DB >> 1876661

Selective dopamine antagonists reduce nicotine self-administration.

W A Corrigall1, K M Coen.   

Abstract

The effects of selective D1 (SCH23390) and D2 (spiperone) dopamine antagonists, as well as of haloperidol, were examined on nicotine self-administration, food-maintained responding, and locomotor activity in rats. Antagonists reduced both operant responding and locomotor activity. Response patterns indicated that motor impairment was not the cause of the decreases, since responding was attenuated only in the latter half of operant sessions. Locomotor activity scores were significantly reduced by SCH23390, but not by spiperone. The effects of dopamine antagonists on nicotine self-administration are different from the effects of these antagonists on cocaine self-administration. Results are discussed in terms of the role of dopamine in drug reinforcement versus its role in sensorimotor integration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876661     DOI: 10.1007/bf02244174

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats.

Authors:  C Reavill; I P Stolerman
Journal:  J Psychopharmacol       Date:  1987-01       Impact factor: 4.153

2.  Action of nicotine on accumbens dopamine and attenuation with repeated administration.

Authors:  E P Lapin; H S Maker; H Sershen; A Lajtha
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

3.  Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation.

Authors:  F J Vaccarino; W A Corrigall
Journal:  Brain Res Bull       Date:  1987-11       Impact factor: 4.077

Review 4.  A psychomotor stimulant theory of addiction.

Authors:  R A Wise; M A Bozarth
Journal:  Psychol Rev       Date:  1987-10       Impact factor: 8.934

5.  Effects of 6-OHDA lesions in the nucleus accumbens on the acquisition of self injection of heroin under schedule and non schedule conditions in rats.

Authors:  G Singer; M Wallace
Journal:  Pharmacol Biochem Behav       Date:  1984-05       Impact factor: 3.533

6.  Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.

Authors:  P B Clarke; A Pert
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

7.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Nicotinic effects on the firing pattern of midbrain dopamine neurons.

Authors:  J Grenhoff; G Aston-Jones; T H Svensson
Journal:  Acta Physiol Scand       Date:  1986-11

9.  Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat.

Authors:  G Singer; M Wallace; R Hall
Journal:  Pharmacol Biochem Behav       Date:  1982-09       Impact factor: 3.533

10.  Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine.

Authors:  G Mereu; K W Yoon; V Boi; G L Gessa; L Naes; T C Westfall
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

View more
  75 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 2.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

3.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

4.  Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.

Authors:  Graciela N Balerio; Ester Aso; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 5.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

6.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

8.  Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes.

Authors:  Laura E O'Dell; Luis A Natividad; Joseph A Pipkin; Francisco Roman; Ivan Torres; Jesus Jurado; Oscar V Torres; Theodore C Friedman; John M Tenayuca; Arbi Nazarian
Journal:  Addict Biol       Date:  2013-07-08       Impact factor: 4.280

9.  Acquired appetitive responding to intravenous nicotine reflects a Pavlovian conditioned association.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

10.  Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.

Authors:  M E Benwell; D J Balfour; H M Lucchi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.